Test Price
2,800 AEDโ Home Collection Available
CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
- โ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- โ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- โ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by Consultant Medical Genetics.
- โ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- โ Price: 2,800 AED inclusive of home collection and comprehensive molecular report.
Test Overview & Methodology
The CFAP298 Genetic Test identifies pathogenic variants in the CFAP298 gene responsible for primary ciliary dyskinesia type 26 (PCD26), a rare autosomal recessive disorder characterised by chronic otitis media, rhinosinusitis, and progressive bronchiectasis. This NGS-based assay provides definitive molecular diagnosis with 99.9% analytical sensitivity.
| Feature | Our CFAP298 NGS Test | Closest Alternative (Panel/Limited Sequencing) |
|---|---|---|
| Precision | Full gene sequencing (99.9% analytical sensitivity) | Selected exons only; may miss novel or deep intronic variants |
| Method | NGS (Illumina NovaSeq) + Sanger confirmation | Sanger sequencing or targeted panel with limited coverage |
| Turnaround | 3 to 4 weeks | Often 5โ6 weeks or unevaluable for full gene |
Physician Insight & Safety Protocols
โAs a clinical geneticist, I understand the diagnostic odyssey many families face with unexplained recurrent infections. This test provides a definitive molecular diagnosis, allowing targeted surveillance and multidisciplinary care. Remember that a negative result does not exclude all ciliary disorders; clinical correlation remains essential. We are here to guide you through the entire process.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Pre-Test Advisory
โ ๏ธ Do not discontinue prescribed medication without consulting your doctor.
If you have received a whole blood transfusion or allogeneic bone marrow transplant within the last 90 days, please inform our team as donor DNA may interfere with results.
Exclusion Criteria & Emergency Red Flags
- Not suitable for: individuals who have received a recent whole blood transfusion or allogeneic bone marrow transplant (โค90 days) as donor DNA may confound results.
- Seek emergency care immediately (call 998) if the patient develops acute respiratory distress, high fever with cyanosis, or syncope; this genetic test is not intended for acute diagnosis.
- Testing is not recommended for asymptomatic minors without parental consent and formal genetic counselling, in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the CFAP298 gene test, and why is it recommended?
The CFAP298 NGS test diagnoses primary ciliary dyskinesia type 26, a rare genetic disorder causing chronic ear, sinus, and lung infections. It identifies disease-causing mutations in the CFAP298 gene, enabling early targeted intervention. A positive result guides tailored respiratory care and fertility counselling.
2. How is the sample collected, and how long will results take?
A simple blood draw or a drop on an FTA card is collected at home by our certified phlebotomist; results are ready in 3โ4 weeks. The process is virtually painless and requires no fasting. You receive a comprehensive molecular report interpreted by our clinical geneticists.
3. Do I need a doctorโs referral or genetic counselling before this test?
Yes, a doctorโs referral and pre-test genetic counselling are mandatory to ensure clinical appropriateness and informed consent. Our team arranges a teleconsultation with a DHA-licensed genetic counsellor prior to sample collection. This meeting explains the inheritance pattern, possible outcomes, and implications for family members.
UAE Regulatory & Data Privacy Adherence
This genetic testing service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient genetic data is encrypted, stored on secure servers within the UAE, and never shared without explicit consent. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Whole blood (EDTA), Extracted DNA, FTA card |
| Methodology Used | Next Generation Sequencing (NGS) + Sanger confirmation |
| ICD-10-CM Code | Q34.8 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians